May 10th, 2011 by BarbaraFicarraRN in Health Tips
No Comments »
Thanks to Laura Landro for shining light on unsafe injections in her WSJ blog, “Unsafe Injection Practices Persist Despite Education Efforts.”
Landro writes:
“A new push is underway to eliminate unsafe injection practices, which remain a persistent safety problem despite years of efforts to educate clinicians about the risks of re-using needles, syringes and drug vials.
In the U.S., failure to follow safe practices in delivering intravenous medications and injections has resulted in more than 30 outbreaks of infectious disease including hepatitis C, and the notification of more than 125,000 patients about potential exposure just in the last decade, according to health-care purchasing alliance Premier Inc.”
As a registered nurse this is unthinkable. Learning to administer injections safely is “patient care 101.” There is no excuse for any health care professional to unsafely inject patients.
Patients in the hospital, ambulatory surgical centers or outpatient settings, should expect that their nurses, doctors and other clinicians are administering injections safely. Read more »
*This blog post was originally published at Health in 30*
May 9th, 2011 by Iltifat Husain, M.D. in Health Tips
No Comments »
Cancer.net, an oncologist approved cancer information site from the American Society of Clinical Oncology (ASCO), has released a free iPhone and iPad app — full of handy features for cancer patients.
The free app allows cancer patients and their family members to look up pertinent information based on cancer type and download a wealth of oncology related information in the form of videos, podcasts, and up to date articles.
Where the app truly shines is in there key features: Ability to store questions, medications and symptoms. The way this app implements these key features is absolutely stunning, and makes the application a must have for cancer patients and their family members.
This review will explore these features and how your patients can use this app.
*This blog post was originally published at iMedicalApps*
May 9th, 2011 by Toni Brayer, M.D. in News
No Comments »
The top 10 prescribed drugs in the U.S. for 2010 in order of prescriptions written are:
- Hydrocodone (combined with acetaminophen) — 131.2 million prescriptions
- Generic Zocor (simvastatin), a cholesterol-lowering statin drug — 94.1 million prescriptions
- Lisinopril (brand names include Prinivil and Zestril), a blood pressure drug — 87.4 million prescriptions
- Generic Synthroid (levothyroxine sodium), synthetic thyroid hormone — 70.5 million prescriptions
- Generic Norvasc (amlodipine besylate), an angina/blood pressure drug — 57.2 million prescriptions
- Generic Prilosec (omeprazole), an antacid drug — 53.4 million prescriptions (does not include over-the-counter sales)
- Azithromycin (brand names include Z-Pak and Zithromax), an antibiotic — 52.6 million prescriptions
- Amoxicillin (various brand names), an antibiotic — 52.3 million prescriptions
- Generic Glucophage (metformin), a diabetes drug — 48.3 million prescriptions
- Hydrochlorothiazide (various brand names), a water pill used to lower blood pressure — 47.8 million prescriptions.
Notice that most of these are generic so they aren’t the ones that make the most money for Big Pharma. Those drugs are not offered in generic and they brought in n $307 billion in 2010. What was number one? Drumroll……..
Lipitor, a cholesterol lowering statin.
In case you wondered who is paying for these drugs…Commercial insurance helped pay for 63% of all prescriptions. Medicare Part D (Federal government) paid for 22% of prescriptions. The average co-payment for a prescription was $10.73. The average co-payment for a branded drug was $22.73.
If you are paying for prescriptions, make sure you ask your physician if it is available in generic. It can save you a lot of $$.
*This blog post was originally published at EverythingHealth*
May 9th, 2011 by GruntDoc in News, True Stories
2 Comments »
Absent other information, the referred to ‘rodent poison’ is probably a superwarfarin. It’s like regular people-coumadin, but superconcentrated. It kills rodentia by causing them to bleed to death.
Which makes the ‘gas effect’ seem really odd, but possibly explainable.
A patient who apparently ingested rodent poison and is emitting potentially harmful gasses has created a hazardous material situation at St. Joseph Mercy Hospital in Ann Arbor.
The man is isolated in his room in the medical intensive care unit on the hospital’s sixth floor, 5301 McAuley at East Huron River Drive, hospital spokeswoman Lauren Jones said this afternoon.
via Patient emits potentially harmful gas; hazmat called to Ann Arbor hospital | Detroit Free Press | freep.com.
Two thoughts: 1) I sincerely hope this patient recovers, and 2) if this is just upper GI bleed smell someones’ going to have rotten egg smell on their face.
I looked up superwarfarins, found a couple of interesting case reports, but none that talk about abnormal gases.
(For the uninitiated, the smell of digested blood is amazingly awful. It’ll make experienced, hard ED staff retch). I can understand why the smell would set off alarms, except that it’s not that uncommon, so it shouldn’t be a surprise.
It’ll be interesting to see what come of this.
Lighting matches in the hospital is a nono, by the way.
*This blog post was originally published at GruntDoc*
May 9th, 2011 by RyanDuBosar in News, Research
No Comments »
One-third (33.5%) of female heart attack patients receive surgery or angioplasty compared to nearly half (45.6%) of men, and among heart attack patients receiving an intervention such as coronary bypass surgery or angioplasty, women had a 30% higher death rate compared to men, reports HealthGrades.
The findings are based on an analysis of more than 5 million Medicare patient records from 2007 to 2009 and focused on 16 of the most common procedures and diagnoses among women.
The most noticeable disparities were in cardiovascular care. Heart disease is the #1 killer of women in America, surpassing all forms of cancer combined, the company said in a press release. Read more »
*This blog post was originally published at ACP Internist*
